Task: Answer the multiple choice question.
Question: Which drug exhibits a 8.496% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, or c without using any other words.
Options:
(a) CCCCNC(=O)c1ccc2c(c1)N(C)C(=O)c1ccccc1S2
(b) Cc1c(C)c2cc(Cl)c(O)c(CN3CCCC(C)C3)c2oc1=O
(c) CN(C)CCCNc1ncnc2c1cnn2-c1ccccc1
Answer: b. Cc1c(C)c2cc(Cl)c(O)c(CN3CCCC(C)C3)c2oc1=O
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Cc1c(C)c2cc(Cl)c(O)c(CN3CCCC(C)C3)c2oc1=O
Cc1c(C)c2cc(Cl)c(O)c(CN3CCCC(C)C3)c2oc1=O
6-chloro-7-hydroxy-3,4-dimethyl-8-[(3-methylpiperidin-1-yl)methyl]chromen-2-one